Lv4
676 积分 2024-05-15 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
5个月前
已完结
A competitive ligand binding assay for detection of neutralizing antibodies against an insulin analog
6个月前
已完结
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods
8个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
8个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
10个月前
已完结
PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS
10个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1年前
已完结
皖公网安备34019202002308
